Request Sample

Global Tuberculosis (TB) Diagnostics Market Insights and Forecast to 2028

SKU ID : QYR-19941935 | Publishing Date : 11-Jan-2022 | No. of pages : 108

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Market Analysis and Insights: Global Tuberculosis (TB) Diagnostics Market
The global Tuberculosis (TB) Diagnostics market size is projected to reach US$ 3592.2 million by 2028, from US$ 2630 million in 2021, at a CAGR of 4.5% during 2022-2028.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis (TB) Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis (TB) Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis (TB) Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis (TB) Diagnostics market.
Global Tuberculosis (TB) Diagnostics Scope and Market Size
Tuberculosis (TB) Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tuberculosis (TB) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics

Segment by Application

Diagnostic Laboratories

By Company

Thermo Fisher Scientific
Hain Lifescience
Oxford Immunotec

By Region

North America
United States
Nordic Countries
Rest of Europe
South Korea
Southeast Asia
Rest of Asia
Latin America
Rest of Latin America
Middle East & Africa
Saudi Arabia
Rest of MEA

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.